ImmunoGenesis to Present Pre-Clinical Data from Lead Program at Society for Immunotherapy of Cancer Conference

By WebmasterNovember 3, 2022November 1st, 2024No Comments

ImmunoGenesis to Present Pre-Clinical Data from Lead Program at Society for Immunotherapy of Cancer Conference

Previous PostENB Therapeutics Announces Poster Presentation at the 2022 Summit for Cancer Immunotherapy
Next PostSenzo Receives Funding from the Biomedical Advanced Research and Development Authority (BARDA) to Advance Its PCR-Accurate Lateral Flow COVID-19 Test